COVID-19 US Information Center

Transmission electron microscopic image of an isolate from a case of COVID-19

Novartis is responding to COVID-19 with the safety of our associates and patients we serve as our main concern. We continue to contribute to global research efforts, support local communities and ensure stable supply and price of essential medicines. This US information center provides updates, guidance and other resources.

Information update about the Novartis CAN-COVID trial

Novartis development specialist working on a lab.
The CAN-COVID clinical trial has been one of the ways Novartis is drawing on its global resources and scientific expertise in response to the COVID-19 pandemic.

Learn More

Life Science Companies and the Bill & Melinda Gates Foundation: Joint Communique

Novartis scientists working in a lab
Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.

Learn More
Novartis US response to COVID-19

Woman working from home on her computer. credit : Coursera
Since the first reports of the COVID-19 outbreak globally and in the US, our primary concern at Novartis has and continues to be the health and safety of our associates and patients.

Learn More
Novartis US COVID-19 Initiatives

Man in front of computer monitor
We recognize the profound impact that COVID-19 has had on patients and physicians in the US, and have worked to create solutions in a time of uncertainty and change.

Learn More
Coronavirus disease (COVID-19) Global updates

Illustration: Coronavirus (Centers for Disease Control and Prevention)
As Novartis continues to closely monitor the coronavirus situation, our primary concern is the health and safety of our associates and patients globally.

Learn More
Novartis COVID-19 Global Information Center

Illustration of the coronavirus created at the Centers for Disease Control and Prevention (CDC)

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Enter

Related Links